Arkolith/Insider Trading/NXL/Form 4

Owens David

Chief Medical Officer, DirectorNexalin Technology, Inc. (NXL) · full profile →Form 4 · filed Oct 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2022Buy(P)3K$0.40$1K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-23-006449) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML